Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammation

FEBS Letters - Tập 390 - Trang 165-169 - 1996
Flora Beiche1, Stefan Scheuerer1, Kay Brune1, Gerd Geisslinger1, Margarete Goppelt-Struebe2
1Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nürnberg, Universitätsstr. 22, D-91054 Erlangen, Germany
2Department of Medicine IV, University of Erlangen-Nürnberg, Loschgestr. 8, D-91054 Erlangen, Germany

Tóm tắt

Prostaglandins (PG) have been described as mediators in spinal nociceptive processing after peripheral inflammation. Enzymes essential for PG biosynthesis, cyclooxygenase isozymes COX‐1 and COX‐2, have not yet been investigated in the spinal cord. In two studies on rats with adjuvant‐induced peripheral inflammation levels of mRNA expression of both COX isoforms were analyzed in the lumbar section of the spinal cord using reverse transcription‐polymerase chain reaction (RT‐PCR) technique. We could show that mRNA of both COX isoforms is expressed constitutively in the spinal cord with COX‐2 as the predominant isoform. Six hours after induction of peripheral inflammation, levels of COX‐2 mRNA expression were raised significantly in respect to untreated control rats and returned to baseline within 3 days after induction of inflammation. COX‐2 might therefore be regarded as the COX isozyme responsible for spinal PG release in nociceptive processing under a peripheral inflammatory stimulus.

Tài liệu tham khảo

10.1016/0092-8674(95)90109-4 10.1007/BF00666095 10.1016/0952-3278(95)90039-X 10.1172/JCI117185 10.1016/0005-2760(91)90032-D 10.1006/abbi.1993.1601 1994 K. Seibert Y. Zhang K. Leahy S. Hauser J. Masferrer W. Perkins L. Lee P. Isaakson Proc. Natl. Acad. Sci. USA 12013 12017 10.1172/JCI117620 10.1002/cne.903550208 10.1016/0896-6273(93)90192-T 10.1074/jbc.270.41.24615 10.1146/annurev.ph.41.030179.003321 10.1152/ajplegacy.1966.211.4.998 10.1016/0304-3940(90)90464-K 1982 Raven Press New York T.L. Yaksh H.J.M. Barrett J. Hirsh J.F. Mustard Acetylsalicylic Acid: New Uses for an Old Drug 137 151 10.1126/science.1381521 10.1016/0076-6879(88)62089-1 10.1016/0003-2697(87)90021-2 10.1016/S0021-9258(17)31602-2 10.1093/nar/13.7.2485 10.1006/abbi.1993.1485 10.1016/0014-2999(78)90265-0 10.1523/JNEUROSCI.08-04-01346.1988 10.1016/0006-8993(90)90723-O 10.1038/newbio231232a0 10.2165/00003495-199400475-00004 10.1097/00001756-199307000-00010 Malmberg A.B., 1992, J. Pharmacol. Exp. Ther., 263, 136 Meller S.T., 1993, Soc. Neurosci. Abstr., 19, 967 10.1016/0024-3205(94)00555-9 10.2165/00003495-199400475-00006 10.2165/00003495-199400475-00005 Neugebauer V., 1995, J. Pharmacol. Exp. Ther., 275, 618 10.1523/JNEUROSCI.14-11-06423.1994